Мінскі тафсір 1686 г. Вынікі апошніх даследаванняў
نویسندگان
چکیده
منابع مشابه
06 Deaton 1686.qxd
THE EFFECTIVENESS OF DEVELOPMENT ASSISTANCE is a topic of great public interest. Much of the public debate among non-economists takes it for granted that, if the funds were made available, development would follow: Pogge (2005), Singer (2004), and at least some economists agree (Sachs 2005, 2008). Others, most notably Easterly (2006), are deeply sceptical, a position that has been forcefully ar...
متن کاملC3nr33492a 1678..1686
Kaposi's sarcoma (KS) is an infectious cancer occurring most commonly in human immunodeficiency virus (HIV) positive patients and in endemic regions, such as Sub-Saharan Africa, where KS is among the top four most prevalent cancers. The cause of KS is the Kaposi's sarcoma-associated herpesvirus (KSHV, also called HHV-8), an oncogenic herpesvirus that while routinely diagnosed in developed natio...
متن کاملDmd052548 1686..1694
Despite metronidazole’s widespread clinical use since the 1960s, the specific enzymes involved in its biotransformation have not been previously identified. Hence, in vitro studies were conducted to identify and characterize the cytochrome P450 enzymes involved in the formation of the major metabolite, 2-hydroxymetronidazole. Formation of 2-hydroxymetronidazole in human liver microsomes was con...
متن کاملThe "Capella Stenoniana" in Florence: the tomb of blessed Niels Stensen (1638-1686).
The "Capella Stenoniana" (Niels Stensen chapel) situated in the Basilica of San Lorenzo in Florence is the tomb of the anatomist and founder of modern geology Niels Stensen (1638-1686). It displays commemorative plaques and contains a sarcophagus with Stensen's mortal remains. The tomb of Blessed Stensen, whose canonization process is under way, is always covered with papers with requests for i...
متن کاملStructural basis of mutant-selectivity and drug-resistance related to CO-1686
Non-small-cell lung cancers (NSCLCs) caused by activating mutations in the kinase domain of epidermal growth factor receptor (EGFR) initially respond to first-generation reversible drugs gefitinib and erlotinib. However, clinical efficacy is limited due to the development of drug-resistance that in more than half of the cases are driven by the secondary T790M mutation. CO-1686 is one of the thi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Poznańskie Studia Polonistyczne. Seria Językoznawcza
سال: 2018
ISSN: 2450-4939,1233-8672
DOI: 10.14746/pspsj.2017.24.2.10